Boiron SA Asset Resilience Ratio
Boiron SA asset resilience ratio. Boiron SA (BOI) has an Asset Resilience Ratio of -0.13% as of December 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See BOI defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Boiron SA (2001–2023)
Asset resilience ratio of Boiron SA from 2001 to 2023. This chart shows how Boiron SA's Asset Resilience Ratio has changed over time. Read Boiron SA (BOI) total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Boiron SA's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Boiron SA (BOI) total assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €-747.00K | -0.13% |
| Total Liquid Assets | €-747.00K | -0.13% |
Asset Resilience Insights
- Limited Liquidity: Boiron SA maintains only -0.13% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Boiron SA Industry Peers by Asset Resilience Ratio
Compare Boiron SA's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt
F:RIG2 |
Drug Manufacturers - Specialty & Generic | 0.20% |
|
Changchun High & New Technology Industries Group Inc
SHE:000661 |
Drug Manufacturers - Specialty & Generic | 5.50% |
|
Chengdu Kanghong Pharmaceuticals Group Co Ltd
SHE:002773 |
Drug Manufacturers - Specialty & Generic | 29.37% |
|
Zhejiang Hisun Pharmaceutical Co Ltd
SHG:600267 |
Drug Manufacturers - Specialty & Generic | 0.01% |
|
Shenzhen Chipscreen Biosciences Co
SHG:688321 |
Drug Manufacturers - Specialty & Generic | 5.10% |
|
Cronos Group Inc
TO:CRON |
Drug Manufacturers - Specialty & Generic | 69.94% |
|
Jiangsu Kanion Pharmaceutical Co Ltd
SHG:600557 |
Drug Manufacturers - Specialty & Generic | 0.29% |
|
HPGC Renmintongtai Pharmaceutical Corp
SHG:600829 |
Drug Manufacturers - Specialty & Generic | 0.00% |
Boiron SA Asset Resilience Ratio by Year (2001–2023)
Boiron SA asset resilience ratio by year from 2001 to 2023. The table below shows the annual Asset Resilience Ratio data for Boiron SA.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-12-31 | -0.13% | €-747.00K ≈ $-873.32K |
€590.20 Million ≈ $690.01 Million |
-0.09pp |
| 2022-12-31 | -0.03% | €-260.00K ≈ $-303.97K |
€789.49 Million ≈ $923.00 Million |
+0.02pp |
| 2021-12-31 | -0.05% | €-398.00K ≈ $-465.30K |
€770.70 Million ≈ $901.03 Million |
0.00pp |
| 2020-12-31 | -0.05% | €-397.00K ≈ $-464.13K |
€781.82 Million ≈ $914.03 Million |
+0.00pp |
| 2019-12-31 | -0.05% | €-411.00K ≈ $-480.50K |
€764.28 Million ≈ $893.53 Million |
-0.06pp |
| 2015-12-31 | 0.01% | €41.00K ≈ $47.93K |
€695.45 Million ≈ $813.05 Million |
+0.49pp |
| 2012-12-31 | -0.48% | €-2.79 Million ≈ $-3.26 Million |
€579.28 Million ≈ $677.24 Million |
-0.92pp |
| 2001-12-31 | 0.44% | €905.00K ≈ $1.06 Million |
€205.86 Million ≈ $240.67 Million |
-- |
About Boiron SA
Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary homeopathic medicines and homeopathic specialties; and other healthcare products, including medical devices, invitro diagnostics, herbal medicine, food supplements, cosmetics, and CBD-based products. It also provides homeopathic specialties compr… Read more